Debasish Borbora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Debasish Borbora has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Kanwar Narain
Regional Medical Research Center-Northeast Region (RMRC-NE)-ICMR, Dibrugarh 786001, India
3 shared publications Hemonta Kr. Dutta
Department of Pediatric Surgery, Assam Medical College and Hospital, Dibrugarh, Assam, India
2 shared publicationsHidam Bishworjit Singh
2 shared publicationsJagadish Mahanta
Regional Medical Research Centre, NE Region (ICMR), Dibrugarh, Assam, India
2 shared publicationsMauchumi Baruah
Department of Physiology, Assam Medical College, Dibrugarh, Assam, India
2 shared publicationsSunali Saikia
Department of Biotechnology, Gauhati University, Guwahati 781014, Assam, India
2 shared publications
Latest Publications
- 28 October 2026
- Published by Wiley in Advanced Engineering Materials
Ni‐Doped Reduced Graphene Oxide/WS 2 Heterostructure as a Dual Function Photocatalyst for Photo/Electrochemical Water Splitting and Antibacterial Activity
The integration of WS 2 with Ni‐doped reduced graphene oxide (Ni‐rGO) forms a novel WS 2 /Ni‐rGO heterostructure that leverages synergistic effects from enhanced electrical conductivity, abundant active sites, and accelerated charge transfer, positioning it as a highly promising electrocatalyst for the hydrogen evolution reaction (HER). To the best of our knowledge, this WS 2 /Ni‐rGO system has not been previously reported, highlighting its novelty and potential significance. Detailed optical investigations based on Urbach energy analysis revealed that Ni incorporation increases the Urbach energy, indicating the generation of defect‐induced localized states and enhanced electronic disorder that facilitate charge transport and catalytic activity. The catalyst achieved an impressive H 2 evolution rate of 1.8 mmol h −1 g −1 , with production increasing steadily without saturation, reaching a cumulative 7.17 mmol g −1 over 4 h. Apparent quantum yield (AQY) was calculated at 14.13%, underscoring exceptional light‐to‐hydrogen conversion efficiency. Tafel slopes of 143.8 mV dec −1 under photoelectrochemical (PEC) and 157.72 mV dec −1 under electrocatalytic (EC) conditions indicate favorable H + adsorption and H 2 production via the Volmer–Heyrovsky mechanism. Chronoamperometric tests over 10 000 s confirmed long‐term durability with sustained performance. Furthermore, WS 2 /Ni‐rGO (WNG) exhibited potent antibacterial activity under UV irradiation (253 and 365 nm), completely suppressing proliferation of Gram‐negative Escherichia coli and Gram‐positive Staphylococcus aureus in spot assays, with no radial colony expansion at 24, 48, or 72 h, in stark contrast to untreated controls showing diameters from 0.20 cm (24 h) to 1.80–2.70 cm (72 h).
- 28 October 2026
- Published by Wiley in Advanced Engineering Materials
Ni‐Doped Reduced Graphene Oxide/WS 2 Heterostructure as a Dual Function Photocatalyst for Photo/Electrochemical Water Splitting and Antibacterial Activity
The integration of WS 2 with Ni‐doped reduced graphene oxide (Ni‐rGO) forms a novel WS 2 /Ni‐rGO heterostructure that leverages synergistic effects from enhanced electrical conductivity, abundant active sites, and accelerated charge transfer, positioning it as a highly promising electrocatalyst for the hydrogen evolution reaction (HER). To the best of our knowledge, this WS 2 /Ni‐rGO system has not been previously reported, highlighting its novelty and potential significance. Detailed optical investigations based on Urbach energy analysis revealed that Ni incorporation increases the Urbach energy, indicating the generation of defect‐induced localized states and enhanced electronic disorder that facilitate charge transport and catalytic activity. The catalyst achieved an impressive H 2 evolution rate of 1.8 mmol h −1 g −1 , with production increasing steadily without saturation, reaching a cumulative 7.17 mmol g −1 over 4 h. Apparent quantum yield (AQY) was calculated at 14.13%, underscoring exceptional light‐to‐hydrogen conversion efficiency. Tafel slopes of 143.8 mV dec −1 under photoelectrochemical (PEC) and 157.72 mV dec −1 under electrocatalytic (EC) conditions indicate favorable H + adsorption and H 2 production via the Volmer–Heyrovsky mechanism. Chronoamperometric tests over 10 000 s confirmed long‐term durability with sustained performance. Furthermore, WS 2 /Ni‐rGO (WNG) exhibited potent antibacterial activity under UV irradiation (253 and 365 nm), completely suppressing proliferation of Gram‐negative Escherichia coli and Gram‐positive Staphylococcus aureus in spot assays, with no radial colony expansion at 24, 48, or 72 h, in stark contrast to untreated controls showing diameters from 0.20 cm (24 h) to 1.80–2.70 cm (72 h).
- Open Access
- 1 August 2026
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 20 (3) , 2288
Simultaneous Integrated Boost Versus Sequential Boost Chemoradiotherapy Induced Toxicity and Its Association with Oral Candidiasis in Locally Advanced Head and Neck Cancer
Chemoradiotherapy for Locally Advanced Head and Neck Cancer (LAHNC) has varied immensely in the last 20 years with the evolution of conformal Radiotherapy techniques. Whether differences exist in these treatment techniques related to survival and toxicity, remains unanswered. Also, these vulnerable groups of subjects have an enhanced risk of oral Candidiasis, mainly because of immune suppression and mucosal damage. A two-year cross-sectional pilot study was conducted in Barpeta Cancer Centre, Barpeta District, Assam. Two hundred cases with histological confirmation of LAHNC under definitive chemoradiotherapy treatment of 66-70 Gy were included. Sequential boost (SB) was used to treat 130 patients and Simultaneous Integrated Boost (SIB) was used upon 70 patients as separate treatment arms. In both treatment arms Inj. Cisplatin 40 mg/m2 per week was included as a simultaneous chemotherapeutic. Grading of toxicity was done every week after treatment initiation and during follow-up visits at the end of three (3) months post treatment. Overall survival (OS), Recurrence free survival (RFS) and Disease free survival (DFS) were estimated. Saliva samples were collected from each patient during the first follow up and inoculated on SDA with chloramphenicol. Germ tube test, Dalmau plate culture and Chrom Agar inoculation was used for speciation. The most common subtype was oropharyngeal carcinoma with no treatment-related death in either arm. The OS was estimated to be 70% in SB arm and 62% in the SIB treatment Arm, at the end of 2 years. SIB Arm showed high rates of advanced grade toxicities then SB Arm. Oral candidiasis prevalence was 65%, but was higher in SIB (71.4%) then SB arm (61.5%), and Candida albicans (46%) largely outnumbered candida Non-albicans. Significant association was found between high grade mucositis (χ2 = 17.45, P < 0.001), dysphagia (χ2 = 28.79, P < 0.001), dermatitis (χ2 = 42.23, P < 0.001) with Candidal growth. Disease related outcomes showed no changes in both the treating arms. However toxicities and Candidal growth especially Candida albicans showed high association, warranting early interventions with oral care and antifungal therapies.
- 1 August 2026
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 20 (3) , 2288
Open AccessSimultaneous Integrated Boost Versus Sequential Boost Chemoradiotherapy Induced Toxicity and Its Association with Oral Candidiasis in Locally Advanced Head and Neck Cancer
Chemoradiotherapy for Locally Advanced Head and Neck Cancer (LAHNC) has varied immensely in the last 20 years with the evolution of conformal Radiotherapy techniques. Whether differences exist in these treatment techniques related to survival and toxicity, remains unanswered. Also, these vulnerable groups of subjects have an enhanced risk of oral Candidiasis, mainly because of immune suppression and mucosal damage. A two-year cross-sectional pilot study was conducted in Barpeta Cancer Centre, Barpeta District, Assam. Two hundred cases with histological confirmation of LAHNC under definitive chemoradiotherapy treatment of 66-70 Gy were included. Sequential boost (SB) was used to treat 130 patients and Simultaneous Integrated Boost (SIB) was used upon 70 patients as separate treatment arms. In both treatment arms Inj. Cisplatin 40 mg/m2 per week was included as a simultaneous chemotherapeutic. Grading of toxicity was done every week after treatment initiation and during follow-up visits at the end of three (3) months post treatment. Overall survival (OS), Recurrence free survival (RFS) and Disease free survival (DFS) were estimated. Saliva samples were collected from each patient during the first follow up and inoculated on SDA with chloramphenicol. Germ tube test, Dalmau plate culture and Chrom Agar inoculation was used for speciation. The most common subtype was oropharyngeal carcinoma with no treatment-related death in either arm. The OS was estimated to be 70% in SB arm and 62% in the SIB treatment Arm, at the end of 2 years. SIB Arm showed high rates of advanced grade toxicities then SB Arm. Oral candidiasis prevalence was 65%, but was higher in SIB (71.4%) then SB arm (61.5%), and Candida albicans (46%) largely outnumbered candida Non-albicans. Significant association was found between high grade mucositis (χ2 = 17.45, P < 0.001), dysphagia (χ2 = 28.79, P < 0.001), dermatitis (χ2 = 42.23, P < 0.001) with Candidal growth. Disease related outcomes showed no changes in both the treating arms. However toxicities and Candidal growth especially Candida albicans showed high association, warranting early interventions with oral care and antifungal therapies.
- Open Access
- 5 June 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (33) , 30649-30661
Synthesis, characterisation and antibacterial activity of flavone-based Sn( iv ) and Sb( iii ) complexes
Sn( iv ) and Sb( iii ) flavonoid complexes display significant in vitro antibacterial activity, especially against the Gram-positive S. aureus (MTCC 96) probably via rupture of cell membrane as evident from scanning electron microscopic images.
- 5 June 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (33) , 30649-30661
Open AccessSynthesis, characterisation and antibacterial activity of flavone-based Sn( iv ) and Sb( iii ) complexes
Sn( iv ) and Sb( iii ) flavonoid complexes display significant in vitro antibacterial activity, especially against the Gram-positive S. aureus (MTCC 96) probably via rupture of cell membrane as evident from scanning electron microscopic images.
- Open Access
- 18 January 2025
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 16 (1) , 101075
Potentilla fulgens root extract rich in polyphenols ameliorate diabetic foot ulcers in wistar rats via regulating oxidative stress and connective tissue markers
- 18 January 2025
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 16 (1) , 101075
Open AccessPotentilla fulgens root extract rich in polyphenols ameliorate diabetic foot ulcers in wistar rats via regulating oxidative stress and connective tissue markers
- 14 December 2024
- Published by Springer Nature in Journal of Applied Genetics
- Vol. 67 (1) , 103-119
Computational analysis of MYC gene variants: structural and functional impact of non-synonymous SNPs
The MYC proto-oncogene encodes a basic helix-loop-helix leucine zipper (HLH-LZ) transcription factor, acting as a master regulator of genes involved in cellular proliferation, differentiation, and immune surveillance. Dysregulation of MYC is implicated in over 70% of human cancers, driving oncogenic processes through altered gene expression and disrupted cellular functions. Non-synonymous single nucleotide polymorphisms (nsSNPs) within coding regions can significantly impact protein structure and function, leading to abnormal cellular behaviours. This study employed 29 in silico tools to systematically evaluate the deleteriousness of nsSNPs within the MYC gene. These tools assessed the variants' effects on protein structure, disease association, functional domains, and post-translational modification sites. This study investigated if these variants may disrupt protein–protein interactions, critical for MYC’s oncogenic roles and normal cellular functions. Our analysis identified 21 nsSNPs that were predicted to be deleterious and pathogenic. These variants correspond to residues D63H, D63Y, P74L, P75L, N375D, N375I, E378K, E378Q, E378A, E378G, E378V, R379P, R381K, R381T, R382W, L392P, R393C, R393H, R393P, L411H, and L411P. Stability assessments indicated that these variants could destabilise the MYC protein. None of the variants affected post-translational modifications. Protein–protein interaction and docking analysis revealed that variants within bHLH and LZ domains may disrupt MYC/MAX binding, potentially impacting MYC's oncogenic activity and transcriptional regulation. This computational assessment enhances our understanding of genetic variations within the MYC gene and prioritises candidate nsSNPs for experimental validation and therapeutic exploration.
- 14 December 2024
- Published by Springer Nature in Journal of Applied Genetics
- Vol. 67 (1) , 103-119
Computational analysis of MYC gene variants: structural and functional impact of non-synonymous SNPs
The MYC proto-oncogene encodes a basic helix-loop-helix leucine zipper (HLH-LZ) transcription factor, acting as a master regulator of genes involved in cellular proliferation, differentiation, and immune surveillance. Dysregulation of MYC is implicated in over 70% of human cancers, driving oncogenic processes through altered gene expression and disrupted cellular functions. Non-synonymous single nucleotide polymorphisms (nsSNPs) within coding regions can significantly impact protein structure and function, leading to abnormal cellular behaviours. This study employed 29 in silico tools to systematically evaluate the deleteriousness of nsSNPs within the MYC gene. These tools assessed the variants' effects on protein structure, disease association, functional domains, and post-translational modification sites. This study investigated if these variants may disrupt protein–protein interactions, critical for MYC’s oncogenic roles and normal cellular functions. Our analysis identified 21 nsSNPs that were predicted to be deleterious and pathogenic. These variants correspond to residues D63H, D63Y, P74L, P75L, N375D, N375I, E378K, E378Q, E378A, E378G, E378V, R379P, R381K, R381T, R382W, L392P, R393C, R393H, R393P, L411H, and L411P. Stability assessments indicated that these variants could destabilise the MYC protein. None of the variants affected post-translational modifications. Protein–protein interaction and docking analysis revealed that variants within bHLH and LZ domains may disrupt MYC/MAX binding, potentially impacting MYC's oncogenic activity and transcriptional regulation. This computational assessment enhances our understanding of genetic variations within the MYC gene and prioritises candidate nsSNPs for experimental validation and therapeutic exploration.
- 23 October 2024
- Published by Springer Nature in Vegetos
- Vol. 38 (6) , 2437-2446
Antibacterial activity and GC–MS profiling of Stephania glandulifera Miers root extract
- 23 October 2024
- Published by Springer Nature in Vegetos
- Vol. 38 (6) , 2437-2446
Antibacterial activity and GC–MS profiling of Stephania glandulifera Miers root extract
- Open Access
- 22 September 2023
- Published by Slovak University of Agriculture in Nitra in Journal of microbiology, biotechnology and food sciences
- Vol. 13 (3) , e10275
CHARACTERIZATION OF A NEWLY ISOLATED AZO-DYE DEGRADING KLEBSIELLA SP. STRAIN RGUDBI01
Azo-dyes such as crystal violet are commonly used ingredient in all types of dying industries which more often eventually reach water and soil due to washing and disposal practices. They are non-biodegradable inside higher organisms and are less biodegradable due to their xenobiotic character. However, some of the microbes exhibit their extensive potential to degrade such recalcitrants. This study reports the isolation and characterization of a newly isolated Klebsiella sp. strain RGUDBI01 from petroleum-contaminated soil samples. The species-level identification was done by 16S rDNA gene sequencing (ON945611.1). The isolate exhibited 88% azo-dye degradation just after 3 days of incubation under optimized conditions. The treated samples exhibited a significant increase in the growth of Cicer arietinum seeds compared to the control group. This result suggests that the dye-contaminated samples, after treatment, displayed non-cytotoxic behavior. The strain also showed its potential to tolerate and withstand a wide range of pH, salinity, and substrate concentration which supports its futuristic environmental application. In addition to the above, the strain could also produce biosurfactants with ʋC=C, ʋC=C-H, and ʋC-C functional groups which were evaluated based on FTIR spectral analysis.
- 22 September 2023
- Published by Slovak University of Agriculture in Nitra in Journal of microbiology, biotechnology and food sciences
- Vol. 13 (3) , e10275
Open AccessCHARACTERIZATION OF A NEWLY ISOLATED AZO-DYE DEGRADING KLEBSIELLA SP. STRAIN RGUDBI01
Azo-dyes such as crystal violet are commonly used ingredient in all types of dying industries which more often eventually reach water and soil due to washing and disposal practices. They are non-biodegradable inside higher organisms and are less biodegradable due to their xenobiotic character. However, some of the microbes exhibit their extensive potential to degrade such recalcitrants. This study reports the isolation and characterization of a newly isolated Klebsiella sp. strain RGUDBI01 from petroleum-contaminated soil samples. The species-level identification was done by 16S rDNA gene sequencing (ON945611.1). The isolate exhibited 88% azo-dye degradation just after 3 days of incubation under optimized conditions. The treated samples exhibited a significant increase in the growth of Cicer arietinum seeds compared to the control group. This result suggests that the dye-contaminated samples, after treatment, displayed non-cytotoxic behavior. The strain also showed its potential to tolerate and withstand a wide range of pH, salinity, and substrate concentration which supports its futuristic environmental application. In addition to the above, the strain could also produce biosurfactants with ʋC=C, ʋC=C-H, and ʋC-C functional groups which were evaluated based on FTIR spectral analysis.
- 18 June 2019
- Published by Wiley in Pediatrics International
- Vol. 61 (8) , 759-767
Long telomeres cooperate with p53,MDM2, and p21 polymorphisms to raise pediatric solid tumor risk
Background: While leukocyte telomere length has been linked with altered risk in adult cancer, limited information is available on its association with risk in pediatric solid tumors. We investigated the association of telomeric alterations with risk of pediatric solid tumors. We also investigated whether altered telomeres cooperated with the TP53 rs1042522, MDM2 rs2279744 and CDKN1A (p21cip1) rs1059234 single‐nucleotide polymorphisms to modify cancer risk.Methods: A total of 101 tumor patients and 202 controls were recruited for this age‐ and gender‐matched case–control study. Relative telomere length (RTL) was determined in peripheral blood leukocytes using quantitative real‐time polymerase chain reaction (PCR), and the polymorphisms were genotyped using PCR–restriction fragment length polymorphism.Results: Using median RTL in the healthy controls as a cut‐off, children with longer telomeres were at an increased risk of developing a solid tumor (OR, 2.70; P < 0.01). When participants were categorized according to control RTL quartiles, a significant dose–response relationship was observed (χ2 = 10.95; P < 0.001). The risk for tumors increased nearly threefold (P = 0.001) for the triple interaction RTL × TP53 rs1042522 × p21cip1 rs1059234 compared with the maximum effect of any single factor, although the interaction effect was less than additive. The MDM2 rs2279744 GG genotype reduced pediatric solid tumor risk significantly (OR, 0.51).Conclusion: Combined analysis of telomeres and genetic polymorphisms in the TP53 pathway can provide important clues to understanding pediatric solid tumor etiology.
- 18 June 2019
- Published by Wiley in Pediatrics International
- Vol. 61 (8) , 759-767
Long telomeres cooperate with p53,MDM2, and p21 polymorphisms to raise pediatric solid tumor risk
Background: While leukocyte telomere length has been linked with altered risk in adult cancer, limited information is available on its association with risk in pediatric solid tumors. We investigated the association of telomeric alterations with risk of pediatric solid tumors. We also investigated whether altered telomeres cooperated with the TP53 rs1042522, MDM2 rs2279744 and CDKN1A (p21cip1) rs1059234 single‐nucleotide polymorphisms to modify cancer risk.Methods: A total of 101 tumor patients and 202 controls were recruited for this age‐ and gender‐matched case–control study. Relative telomere length (RTL) was determined in peripheral blood leukocytes using quantitative real‐time polymerase chain reaction (PCR), and the polymorphisms were genotyped using PCR–restriction fragment length polymorphism.Results: Using median RTL in the healthy controls as a cut‐off, children with longer telomeres were at an increased risk of developing a solid tumor (OR, 2.70; P < 0.01). When participants were categorized according to control RTL quartiles, a significant dose–response relationship was observed (χ2 = 10.95; P < 0.001). The risk for tumors increased nearly threefold (P = 0.001) for the triple interaction RTL × TP53 rs1042522 × p21cip1 rs1059234 compared with the maximum effect of any single factor, although the interaction effect was less than additive. The MDM2 rs2279744 GG genotype reduced pediatric solid tumor risk significantly (OR, 0.51).Conclusion: Combined analysis of telomeres and genetic polymorphisms in the TP53 pathway can provide important clues to understanding pediatric solid tumor etiology.
- 1 June 2017
- Published by Elsevier in Pediatric Neurology
- Vol. 71, 29-34
Growth and Psychological Development in Postoperative Patients With Anterior Encephaloceles
- 1 June 2017
- Published by Elsevier in Pediatric Neurology
- Vol. 71, 29-34
Growth and Psychological Development in Postoperative Patients With Anterior Encephaloceles